Top news of the week: 07.07.2020.
#pandemic #biotech #news #pharma #pharmiweb #biospace #lifesciences #pharmaceuticals #biotechnology #ICYMI
Career And Jobs
Biopharma Update on the Novel Coronavirus: July 6
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #vaccine
https://t.co/tS8JJ3ETeD
OpenBiopharma Update on the Novel Coronavirus: July 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 6, 2020.
#3
Seattle Genetics, Genmab turn on TV for a highlight reel in cervical cancer — but a rival biotech promises a better show
https://t.co/RfVU24iRlA
OpenSeattle Genetics, Genmab turn on TV for a highlight reel in cervical cancer — but a rival biotech promises a better show
Seattle Genetics $SGEN and their partners at Genmab $GMAB polished up some positive Phase II numbers for their antibody drug conjugate tisotumab vedotin — you can call it TV — for recurrent ...
RT @IAmBiotech: #ICYMI: Here's how #biotech is the Key to Post #Pandemic Resilience https://t.co/P8de0ppWc5
OpenBiotech is the Key to Post-Pandemic Resilience
In a National Academies webinar, former Secretary of Agriculture Tom Vilsack said, we as a nation have to consider that resiliency is just as important as efficiency. He was talking about ...
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market
https://t.co/NGKSynGq4M
#news #pharma #pharmiweb
OpenRentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market
The key to tackling drug development complexity: Collaboration.LAUPHEIM and RAVENSBURG, Germany, MILFORD, MA, and SKOKIE, IL, USA, July 06, 2020 / B3C newswire / -- Vetter and Rentschler ...
An anonymous investigator spoke to healthcare publication Stat saying the heavily funded biotech had changed the trial’s protocol, pushing back its timeline https://t.co/Z8SyfBHWxF
OpenModerna shares hit by COVID-19 vax trial delay report, but biotech says July start still on track
Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report by Stat said the biotech would have to delay the start of its major phase 3 pandemic vaccine ...
As the new #EU guidelines are enforced, all #biotech facilities are going to experience big changes in their maintenance. #GMP #regulation
https://t.co/GyMvoTTvFr
OpenWhy Biotech Must Change its Cleaning and Disinfection Strategy
As the EU prepares to release new guidelines on good manufacturing practices, it’s time to revise how cleaning is approached in the biotech industry.
British biotech Mission dubs Pfizer lead investor and new R&D partner https://t.co/2bp2gvKK8n https://t.co/kf05HYFWns
OpenBritish biotech Mission dubs Pfizer lead investor and new R&D partner
Pfizer is deepening its already long-term investment and partnership strategy with U.K.-based biotech Mission Therapeutics and its work on selectively inhibiting deubiquitylating enzymes.
Hansa Biopharma announces exclusive agreement with Sarepta Therapeutics to develop and promote imlifidase as pre-treatment ahead of gene therapy in select indications
https://t.co/YjDeFfje2l
#news #pharma #pharmiweb
OpenHansa Biopharma announces exclusive agreement with Sarepta Therapeutics to develop and promote imlifidase as pre-treatment ahead of gene therapy in select indications
Hansa grants Sarepta exclusive license to develop and promote imlifidase as a potential pre-treatment prior to the administration of gene therapy in Duchenne muscular dystrophy and ...